Insider Transactions in Q4 2021 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
22,624
-4.67%
|
$90,496
$4.27 P/Share
|
|
Dec 15
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
49,259
-5.12%
|
$197,036
$4.27 P/Share
|
|
Dec 15
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
17,178
-4.81%
|
$68,712
$4.27 P/Share
|
|
Dec 15
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
15,780
-5.86%
|
$63,120
$4.27 P/Share
|
|
Dec 15
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
17,819
-1.96%
|
$71,276
$4.27 P/Share
|
|
Dec 14
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
10,946
-2.21%
|
$43,784
$4.37 P/Share
|
|
Dec 14
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
23,834
-2.42%
|
$95,336
$4.37 P/Share
|
|
Dec 14
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
8,312
-2.27%
|
$33,248
$4.37 P/Share
|
|
Dec 14
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
7,635
-2.76%
|
$30,540
$4.37 P/Share
|
|
Dec 14
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
8,622
-0.94%
|
$34,488
$4.37 P/Share
|
|
Dec 13
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,422
-1.28%
|
$25,688
$4.42 P/Share
|
|
Dec 13
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
13,983
-1.4%
|
$55,932
$4.42 P/Share
|
|
Dec 13
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,876
-1.32%
|
$19,504
$4.42 P/Share
|
|
Dec 13
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
4,479
-1.59%
|
$17,916
$4.42 P/Share
|
|
Dec 13
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
5,059
-0.55%
|
$20,236
$4.42 P/Share
|